Ray Co

Ray Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ray Co (228670.KQ) as of Nov 22, 2026 is -9.79 B KRW. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -42.05 B KRW — a change of -76.73% (higher).

EBITDA

-9.79 BKRW

YoY

-76.73%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ray Co is 2025 -9.79 B KRW. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ray Co was 2024 -42.05 B KRW. It decreases by -76.73% higher compared to the previous year.

The Ray Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
6.25 B KRW
Jan 1, 2019
14.03 B KRW
Jan 1, 2020
6.45 B KRW
Jan 1, 2021
3.25 B KRW
Jan 1, 2022
19.63 B KRW
Jan 1, 2023
13.79 B KRW
Jan 1, 2024
-42.05 B KRW
Jan 1, 2025
-9.79 B KRW
The Ray Co EBITDA history
YEAREBITDAYoY
-9.79 BKRW-76.73%
-42.05 BKRW-405.00%
13.79 BKRW-29.75%
19.63 BKRW+504.60%
3.25 BKRW-49.68%
6.45 BKRW-54.01%
14.03 BKRW+124.40%
6.25 BKRW+184.30%
2.20 BKRW+65.97%
1.32 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ray Co Stock analysis

What does Ray Co do? Ray Co., Ltd. generates revenue through the manufacturing and sale of advanced technology medical devices, focusing on digital diagnostic systems and digital therapy solutions. The company produces dental radiography equipment such as x-ray systems and cone beam computed tomography (CBCT) systems, alongside 3D scanning, dental computer aided design (CAD), and 3D printers for prosthodontics, orthodontics, and implant surgery. Domestic and overseas markets purchase these products, with the company operating through subsidiaries to distribute its offerings globally. Digital diagnostic systems like dental radiography equipment and CBCT systems are sold to healthcare providers and dental clinics, while digital therapy solutions including 3D scanning and CAD systems target dental laboratories and surgical centers. The firm's product portfolio serves both domestic and international clients, leveraging its subsidiaries for global distribution channels. Ray Co., Ltd. emphasizes advanced technology in its medical device offerings, with digital therapy solutions such as 3D printers and CAD systems being key revenue drivers. The company's focus on dental-specific applications ensures targeted sales to specialized healthcare segments, including prosthodontics, orthodontics, and implant surgery practices. Ray Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ray Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ray Co is -9.79 B KRW in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Ray Co changed from -42.05 B KRW to -9.79 B KRW, representing a -76.73% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Ray Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Ray Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Ray Co

All Key Metrics — Ray Co